Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 355 across all filing types
Latest filing 2021-12-10 Major Shareholding Noti…
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including the reporting entity (K Partners Co., Ltd.), special related parties, and the purpose of holding (management control). This document type is specifically used to notify the market of significant shareholding changes (crossing thresholds), which aligns with the 'Major Shareholding Notification' category.
2021-12-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details changes in share ownership by a major shareholder (K Partners Co., Ltd.) in the company Curocom. This type of filing is a standard regulatory requirement for insiders and major shareholders to disclose their holdings and transactions, which falls under the 'Director's Dealing' (DIRS) category in the provided taxonomy.
2021-12-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This type of filing is used to disclose significant changes in share ownership (often referred to as a 5% rule filing). Based on the provided categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2021-11-15 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 큐로컴' (Curocom Co., Ltd.) for the 3rd quarter of the 25th fiscal year (ending September 30, 2021). It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status, changes in ownership, and contractual relationships (such as collateral agreements) of major shareholders. In the context of global financial reporting, this corresponds to a 'Major Shareholding Notification' (MRQ).
2021-11-08 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) between Curocom and Hana Bank. It details the contract amount, duration, and nature of the services provided. Since this is a specific corporate announcement regarding a business contract that does not fit into the other specialized categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2021-10-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.